Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04725500 · ClinicalTrials.gov registry record · NA

Vector Engineering Clinical

A NA study of COPD, sponsored by Philips Clinical & Medical Affairs Global.

Completed
Registry status
NA
Development phase
42
Enrollment target
2
Study locations

NCT04725500 is a NA study of COPD that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 42 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04725500, a NA study of COPD, has completed, sponsored by Philips Clinical & Medical Affairs Global.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
2
Study locations

Study Summary

This study aimed to validate a novel automatic non-invasive ventilation (NIV) mode that continuously adjusts expiratory positive airway pressure (EPAP) to the lowest value that abolishes tidal expiratory flow limitation (EFL). The investigator conducted a prospective, non-randomized, study on stable chronic obstructive pulmonary disease (COPD) patients that may or may not be treated currently with NIV. Patients were studied in a sleep lab on a single night with the auto - titrating EPAP that adjusts to abolish tidal EFL. The primary endpoint was to evaluate the behavior of the EPAP during the night. Additionally, a sub-group of patients used the device at home for a 2 week period. EPAP behavior was assessed during this 2 week period.

Conditions Studied

Interventions

  • DEVICE Auto-Titrating EPAP

Study Locations (2)

Ohio

  • Pulmonary Rehabilitation Associates - Youngstown

Pennsylvania

  • Jefferson Associates and Internal Medicine - Clairton

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-10-04
Est. Completion 2020-03-03
Phase NA

What the Registry Record Tells You About NCT04725500

The ClinicalTrials.gov registry entry for NCT04725500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Auto-Titrating EPAP is the first listed.

NCT04725500 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04725500 about?

NCT04725500 is a clinical study titled "Vector Engineering Clinical". This study aimed to validate a novel automatic non-invasive ventilation (NIV) mode that continuously adjusts expiratory positive airway pressure (EPAP) to the lowest value that abolishes tidal expiratory flow limitation (EFL). The investigator conducted a prospective, non-randomized, study on stable...

What is the current status of trial NCT04725500?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-10-04. Estimated completion is 2020-03-03.

What conditions does trial NCT04725500 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT04725500?

The interventions under investigation include: Auto-Titrating EPAP (DEVICE).

Who is sponsoring clinical trial NCT04725500?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04725500 being conducted?

This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.